Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives

Regulatory Toxicology and Pharmacology

Volumn 28, Issue 1, 1998, Pages 45-54

  Collins, J F ^a   Brown, J P ^a   Alexeeff, G V ^a   Salmon, A G ^a  

^a CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 NITROPYRENE; 2 METHYLNAPHTHALENE; 2 NITROFLUORENE; 3 METHYLCHOLANTHRENE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ACENAPHTHENE DERIVATIVE; ACRIDINE ORANGE; ANTHRACENE; BENZO[A]PYRENE; BENZO[GHI]PERYLENE; BENZO[K]FLUORANTHENE; BENZ[A]ANTHRACENE; CARBAZOLE DERIVATIVE; CHRYSENE; COAL TAR; COKE; CREOSOTE; CYTOCHROME P450; DIBENZ[A,H]ANTHRACENE; FLUORANTHENE; FLUORENE; MINERAL OIL; NAPHTHALENE; PERYLENE; PHENANTHRENE; POLYCYCLIC AROMATIC HYDROCARBON; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; PYRENE; TOBACCO SMOKE; UNINDEXED DRUG;

AIR POLLUTION; ARTICLE; BONE MARROW TOXICITY; CARCINOGENICITY; CARDIOTOXICITY; CHEMICAL CARCINOGENESIS; DOSE RESPONSE; EXHAUST GAS; GENOTOXICITY; HUMAN; IMMUNOTOXICITY; LIVER TOXICITY; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SOOT; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

EID: 0031784429     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1998.1235     Document Type: Article

References (73)

1. Alexeeff G. V., Satin K., Painter P., Zeise L., Popejoy C., Murchison G. Chromium carcinogenicity: California strategies. Sci. Total Environ. 86:1989;159-168.
2. Anderson E. A. Quantitative approaches to use to assess cancer risk. Risk Anal. 3:1983;277-295.
3. Armstrong E. C., Bonser G. M. Squamous carcinoma of the forestomach and other lesions in mice following oral administration of 3:4:5:6-dibenzcarbazole. Br. J. Cancer. 4:1950;203-211.
4. Bingham E., Falk H. L. The modifying effect of carcinogens on the threshold response. Arch. Environ. Health. 19:1969;779-783.
5. Bryan W. R., Shimkin M. B. Quantitative analysis of dose-response data with three carcinogenic hydrocarbons in strain C3H male mice. J. Natl. Cancer Inst. 9:1943;503-531.
6. Busby W. F. Jr., Stevens E. K., Kellenbach E. R., Cornelisse J., Lugtenburg J. Dose-response relationships of the tumorigenicity of cyclopenta[c,da. Carcinogenesis. 9:1988;741-746.
7. Busby W. F. Jr., Stevens E. K., Martin C. N., Chow F. L., Garner R. C. Comparative lung tumorigenicity of parent and mononitro-polynuclear aromatic hydrocarbons in the BLU:Ha newborn mouse assay. Toxicol. Appl. Pharmacol. 99:1989;555-563.
8. California Department of Health Services, 1985, Guidelines for Chemical Carcinogen Risk Assessments and Their Scientific Rationale, State of California, Health and Welfare Agency, Sacramento, CA.
9. California Department of Health Services (CDHS), 1986, Health Effects of Dibenzodioxins and Dibenzofurans, State of California, Health and Welfare Agency, Sacramento, CA.
10. Cavalieri E. L., Higginbotham S., RamaKrishna N. V., Devanesan P. D., Todorovic R., Rogan E. G., Salmasi S. Comparative dose-response tumorigenicity studies of dibenzo[alpha,ll. Carcinogenesis. 12:1991;1939-1944.
11. Cavalieri E. L., Rogan E. G., Higginbotham S., Cremonesi P., Salmasi S. Tumor-initiating activity in mouse skin and carcinogenicity in rat mammary gland of dibenzo[aa,l. J. Cancer Res. Clin. Oncol. 115:1989;67-72.
12. Chouroulinkov I., Gentil A., Guerin M. Etude de l'activite carcinogene du 9,10-dimethyl-benzanthracene et du 3,4-benzopyrene administres par voie digestive. Bull. Cancer. S4:1967;67-78.
13. Clement Associates, 1987, Comparative Potency Approach for Estimation of the Total Cancer Risk Associated with Exposures to Mixtures of Polycyclic Aromatic Hydrocarbons in the Environment, ICF-Clement Associates, Washington, DC.
14. Clement Associates, 1988, Comparative Potency Approach for Estimating the Cancer Risk Associated with Exposure to Mixtures of Polycyclic Aromatic Hydrocarbons, ICF-Clement Associates, Fairfax, VA.
15. Collins J. F., Brown J. P., Dawson S. V., Marty M. A. Risk assessment for benzo(a. Regul. Toxicol. Pharmacol. 13:1991;170-184.
16. Department of Toxic Substances Control (DTSC), 1992, A toxic equivalency procedure for estimating 2,3,7,8-tetrachlorodibenzo-pp, Supplemental Guidance for Human Health Multimedia Risk Assessments of Hazardous Waste Sites and Permitted Facilities, California Department of Toxic Substances Control, Sacramento, CA, July.
17. Deutsch-Wenzel R. P., Brune H., Grimmer O., Dettbarn G., Misfeld J. Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst. 71:1983;539-544.
18. Finlayson-Pitts B. J., Pitts J. N. Jr. Atmospheric Chemistry: Fundamentals and Experimental Techniques. 1986;Wiley, New York.
19. Flesher J. W., Myers S. R. Rules of molecular geometry for predicting carcinogenic activity of unsubstituted polynuclear aromatic hydrocarbons. Teratog. Carcinog. Mutagen. 11:1991;41-54.
20. Flessel P., Guirguis G. N., Cheng J. C., Chang K-I., Hahn E. S., Twiss S., Wesolowski J. J. Sources of mutagens in Contra Costa County community aerosols during pollution episodes: Diurnal variations and relations to source emissions tracers. Environ. Int. 11:1985;293-301.
21. Gold L., de Veciana M., Backman G., Magaw R., Lopipero P., Smith M., Blumenthal M., Levinson R., Bernstein L., Ames B. Chronological supplement to the Carcinogenic Potency Database: Standardized results of animal bioassays published through December 1982. Environ. Health Perspect. 67:1986;161-200.
22. Gold L., Sawyer C., Magaw R., Backman G., de Veciana M., Levinson R., Hooper N., Havender W., Bernstein L., Peto R., Pike M., Ames B. A carcinogenic potency database of the standardized results of animal bioassays. Environ. Health Perspect. 58:1984;9-319.
23. Gold L., Slone T., Backman G., Eisenberg S., DaCosta M., Wong M., Manley N., Ames B. Third chronological supplement to the Carcinogenic Potency Database: Standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987. Environ. Health Perspect. 84:1990;215-285.
24. Gold L., Slone T., Backman G., Magaw R., da Costa M., Ames B. Second chronological supplement to the Carcinogenic Potency Database: Standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986. Environ. Health Perspect. 74:1987;237-329.
25. Gold L., Slone T., Bernstein L. Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the Carcinogenic Potency Database. Environ. Health Perspect. 79:1989;259-272.
26. Gruenstein M., Shay H., Shimkin M. B. Lack of effect of norethynodrel (Enovid) on methylcholanthrene-induced mammary carcinogenesis in female rats. Cancer Res. 24:1964;1656-1658.
27. Habs M., Schmahl D., Misfeld J. Local carcinogenicity of some environmentally relevant polycyclic aromatic hydrocarbons after lifelong topical application to mouse skin. Arch. Geschwulstforsch. 50:1980;266-274.
28. Halsall C. J., Coleman P. J., Davis B. J., Burnett V., Waterhouse K. S., Harding-Jones P., Jones K. C. Polycyclic aromatic hydrocarbons in U.K. urban air. Environ. Sci. Technol. 28:1994;2380-2386.
29. Hardin J. A., Hinoshite F., Sherr D. H. Mechanisms by which benzo[a. Toxicol. Appl. Pharmacol. 117:1992;155-164.
30. Hecht S. S., Loy M., Maronpot R. R., Hoffman D. A study of chemical carcinogenesis: Comparative carcinogenicity of 5-methylchrysene, benzo(a. Cancer Lett. 1:1976;147-154.
31. Hoffman D., Wynder E. L. Beitrag zur carcinogen Wirkung von Dibenzopyrenen. Z. Krebsforsch. 68:1966;137-149.
32. Hoover S. M., Zeise L., Pease W. S., Lee L. E., Hennig M. P., Weiss L. B., Cranor C. Improving the regulation of carcinogens by expediting cancer potency estimation. Risk Anal. 15:1995;267-280.
33. Howe, R. B. van Landingham, C. 1986, GLOBAL 86, Clement Associates, Ruston, LA.
34. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. Suppl. 7:1987;42.
35. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 46:1989;375.
36. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 65:1996;297-307.
37. Iwagawa M., Maeda T., Izumi K., Otsuka H., Nishifuji K., Ohnishi Y., Aoki S. Comparative dose-response study on the pulmonary carcinogenicity of 1,6-dinitropyrene and benzo[a. Carcinogenesis. 10:1989;1285-1290.
38. Krewski D., Thorslund T., Withey J. Carcinogenic risk assessment of complex mixtures. Tox. Ind. Health. 5:1989;851-867.
39. Krieger, R. K. Wright, J. N. Arey, J. 1997, Ambient monitoring of selected PAH in California. Paper 97-WP100A.06, Air & Waste Management Association 90th Annual Meeting & Exhibition, June 8-13, 1997, Toronto, Ontario, Canada.
40. LaGoy P. C., Quirk T. C. Establishing generic remediation goals for the polycyclic aromatic hydrocarbons: Critical issues. Environ. Health Perspect. 102:1994;348-352.
41. LaVoie E. J., Braley J., Rice J. E., Rivenson A. Tumorigenic activity of non-alternant polynuclear aromatic hydrocarbons in newborn mice. Cancer Lett. 34:1987;15-20.
42. Lee M. L., Novotny M. V., Bartle K. D. Analytical Chemistry of Polycyclic Aromatic Compounds. 1981;Academic Press, New York.
43. Legraverend C., Harrison D. E., Ruscetti F. W., Nebert D. W. Bone marrow toxicity induced by oral benzo[a. Toxicol. Appl. Pharmacol. 70:1983;390-401.
44. MacKenzie K. M., Angevine D. M. Infertility in mice exposedin uteroa. Biol. Reprod. 24:1981;183-191.
45. Marty, M. A. Alexeeff, G. V. Collins, J. F. Blaisdell, R. J. Rosenbaum, J. Lee, L. 1994, Airborne emissions from industrial point sources and associated cancer risks of selected carcinogens in California, The Emissions Inventory: Perception and Reality. Proceedings of an International Specialty Conference, 1086, 1097, Air & Waste Management Association, Pittsburgh.
46. Miller J. A., Sandin R. B., Miller E. C., Rusch H. P. The carcinogenicity of compounds related to 2-acetylaminofluorene. II. Variations in the bridges and the 2-substituent. Cancer Res. 15:1955;188-199.
47. Mrak E. Managing risk in a technical society: The Tanner Bill in California. Regul. Toxicol. Pharmacol. 5:1985;410-415.
48. National Cancer Institute (NCI), 1978, Bioassay of 5-Nitroacenaphthene for Possible Carcinogenicity, U.S. Department of Health, Education, and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.
49. 1, National Toxicology Program, Research Triangle Park, NC.
50. Neal J., Rigdon R. H. Gastric tumors in mice fed benzo(a. Texas Rep. Biol. Med. 25:1967;553-557.
51. Nisbet I. C. T., LaGoy P. K. Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs). Regul. Toxicol. Pharmacol. 16:1992;290-300.
52. Office of Environmental Health Hazard Assessment (OEHHA), 1992, Expedited Cancer Potency Values and Proposed Regulatory Levels for Certain Proposition 65 Carcinogens, Reproductive and Cancer Hazard Assessment Section, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Sacramento, CA.
53. Office of Environmental Health Hazard Assessment (OEHHA), 1994, Part B. Health Assessment, Benzo[a]pyrene as a Toxic Air Contaminant, Air Resources Board and Office of Environmental Health Hazard Assessment, California Environmental Protection Agency.
54. Paigen B., Havens M. B., Morrow A. Effect of 3-methylcholanthrene on the development of aortic lesions in mice. Cancer Res. 45:1985;3850-3855.
55. Penn A., Batastini G., Solomon J., Burns F., Albert R. Dose-dependent size increases of aortic lesions following chronic exposure to 7,12-dimethylbenz(a. Cancer Res. 41:1981;588-592.
56. Phillips D. H. Fifty years of benzo(a. Nature. 303:1983;468-472.
57. Richard A. M., Woo Y. A CASE-SAR analysis of polycyclic aromatic hydrocarbon carcinogenicity. Mutat. Res. 242:1990;285-303.
58. Rosenkranz H. S., Mermelstein R. 6. The mutagenic and carcinogenic properties of nitrated polycyclic aromatic hydrocarbons. Nitrated Polycyclic Aromatic Hydrocarbons. 1986;Verlag, Heidelberg. p. 267-297.
59. Shay H., Gruenstein M., Kessler W. B. Experimental mammary adenocarcinoma of rats: Some consideration of methylcholanthrene dosage and hormonal treatment. J. Natl. Cancer Inst. 27:1961;503-513.
60. Shay H., Gruenstein M., Kessler W. B. Methylcholanthrene induced breast cancer in the rat: Studies on mechanism of inhibition by large doses of estrogen. Severi L. Morphological Precursors of Cancer. 1962;305-308 Division of Cancer Research, Perugia.
61. Snell K. C., Stewart H. L. Pulmonary adenomatosis induced in DBA/2 mice by oral administration of dibenz[a,h. J. Natl. Cancer Inst. 28:1962;1043-1051.
62. Takayama S., Ishikawa T., Nakajima H., Sato S. Lung carcinoma induction in Syrian golden hamsters by intratracheal instillation of 1,6-dinitropyrene. Jpn. J. Cancer Res. (Gann). 75:1985;457-461.
63. Takemura N., Hashida C., Terasawa M. Carcinogenic action of 5-nitroacenaphthene. Br. J. Cancer. 30:1974;481-483.
64. Thyssen J., Althoff J., Kimmerle G., Mohr U. Inhalation studies with benzo(a. J. Natl. Cancer Inst. 66:1981;575-577.
65. United States Environmental Protection Agency (USEPA), 1980, Ambient Water Quality Criteria for Polynuclear Aromatic Hydrocarbons, Office of Water Regulations and Standards, Washington, DC.
66. United States Environmental Protection Agency (USEPA), 1984, Health Effects Assessment for Benzo(a)pyrene, Environmental Criteria and Assessment Office, Cincinnati, OH.
67. Fed. Reg. 51:1986;33992-34003.
68. United States Environmental Protection Agency (USEPA), 1989, Interim Procedures for Estimating Risks Associated with Exposures to Mixtures of Chlorinated Dibenzo-p-Dioxins and -Dibenzofurans (CDDs and CDFs) and 1989 Update, United States Environmental Protection Agency.
69. United States Environmental Protection Agency (USEPA), 1993, Provisional Guidance for Quantitative Risk Assessment of Polycyclic Aromatic Hydrocarbons, United States Environmental Protection Agency.
70. Warshawsky D., Barkley W., Miller M. L., LaDow K., Andringa A. Comparative tumor-initiating ability of 7H-dibenzo(c,ga,j. Toxicology. 71:1992;233-243.
71. Warshawsky D., Barkley W., Bingham U. Factors affecting the carcinogenic potential of mixtures. Fundam. Appl. Toxicol. 29:1993;376-382.
72. Wislocki P. G., Bagan E. S., Lu A. Y. H., Dooley K. L., Fu P. P., Han-Hsu H., Beland F. A., Kadlubar F. F. Tumorigenicity of nitrated derivatives of pyrene, benz[aa. Carcinogenesis. 7:1986;1317-1322.
73. Wynder E. L. Jr., Hoffman D. A study of tobacco carcinogenesis. VII. The role of higher polycyclic hydrocarbons. Cancer. 12:1959;1079-1086.